SCHEMBL7792276

SCHEMBL7792276

O=[N+]([O-])c1cnn2cccnc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 3/20 0.51
AXL P30530 1/20 0.51
CDK2 P24941 1/20 0.47
BMP4 P12644 1/20 0.40
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTT P42858 2/20 0.39
IRAK4 Q9NWZ3 4/20 0.38
HSD11B1 P28845 1/20 0.38
JAK1 P23458 1/20 0.38
PIK3C3 Q8NEB9 1/20 0.38
PDE10A Q9Y233 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.37
BRD4 O60885 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3671111 0.72 ALDH1A1 (0.43) POLBHTTPDE10ANPC1RAB9A
SCHEMBL28947639 0.72 SMPD3 (0.66) SMPD3AXLCDK2BMP4HTT
SCHEMBL2682919 0.71 SMPD3 (0.55) SMPD3AXLCDK2BMP4HTT
SCHEMBL30385323 0.71 POLB (0.41) POLBL3MBTL1HTTSMN1; SMN2NPC1
SCHEMBL1942256 0.70 PIK3CD (0.44) SMN1; SMN2ALDH1A1PTGS2DRD3
SCHEMBL5761567 0.70 TDP1 (0.39) POLBHTTSMN1; SMN2NPC1RAB9A
SCHEMBL29088984 0.70 L3MBTL1 (0.38) POLBL3MBTL1ALDH1A1MAPT
SCHEMBL17747503 0.70 PIK3CA (0.52)
SCHEMBL17697728 0.69 SMPD3 (0.51) SMPD3AXLCDK2BMP4HTT
SCHEMBL15336871 0.68 SMPD3 (0.60) SMPD3AXLCDK2BMP4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916771-B Multi-target antitumor compound and preparation method and application thereof 浙江华海药业股份有限公司 2025-04-01 CN disclosed
CN-113354649-B Novel crystal form 阵列生物制药公司 2024-12-10 CN disclosed
CN-109414442-B Liquid preparation of compound 洛克索肿瘤学股份有限公司 2024-03-29 CN disclosed
WO-2024046409-A1 HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 江苏恒瑞医药股份有限公司 2024-03-07 WO disclosed
CN-114163445-B Larotinib intermediate and preparation method thereof 重庆医科大学 2023-06-20 CN disclosed
CN-114163445-B Larotinib intermediate and preparation method thereof 重庆医科大学 2023-06-20 CN disclosed
CN-116262739-A Nitrogen-containing aryl derivative regulator, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-06-16 CN disclosed
CN-111138333-B Preparation method of (R) -2- (2, 5-difluorophenyl) -pyrrolidine 上海复星星泰医药科技有限公司 2023-05-23 CN disclosed
US-20010020310-A1 Compositions for dyeing keratinous fibres, containing 3-aminopyrazolo[1,5-a]pyrimidines, method of dyeing, and novel 3-aminopyrazolo[1,5-a]pyrimidines L'OREAL S.A. 2001-09-13 US disclosed
US-6248137-B1 Compositions for dyeing keratinous fibres, containing 3-aminopyrazolo [1,5-a]pyrimidines, method of dyeing and novel 3-aminopyrazolo [1,5-a]pyrimidines L'OREAL S.A. (FR) 2001-06-19 US disclosed
EP-0926149-B1 Keratin fibre dye composition containing 3-aminopyrazolo-(1,5-a)-pyrimidines, dyeing method , 3-aminopyrazolo-(1,5-a)-pyrimidines and their preparation OREAL (FR) 2001-03-07 EP disclosed
EP-0926149-A1 Keratin fibre dye composition containing 3-aminopyrazolo-(1,5-a)-pyrimidines, dyeing method , 3-aminopyrazolo-(1,5-a)-pyrimidines and their preparation L'OREAL (FR) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020310-A1 Compositions for dyeing keratinous fibres, containing 3-aminopyrazolo[1,5-a]pyrimidines, method of dyeing, and novel 3-aminopyrazolo[1,5-a]pyrimidines DPYD, KRT18, PNPO SMPD3 4078/4885AXL 1232/4885CDK2 1090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.